MAPT and tauopathy: We first aimed to determine if the administration of NIR light treatments in two mouse models of tauopathies, hTau (accumulation of tau) and 3xTgAD (accumulation of Aβ and tau), would reduce the synaptic accumulation of tau oligomers.